Related references
Note: Only part of the references are listed.Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Glutamate and the neural basis of the subjective effects of ketamine
J. F. William Deakin et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Impact of the Brain-Derived Neurotrophic Factor Val66Met Polymorphism on Levels of Hippocampal N-Acetyl-Aspartate Assessed by Magnetic Resonance Spectroscopic Imaging at 3 Tesla
Alexa J. Stern et al.
BIOLOGICAL PSYCHIATRY (2008)
Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder
Sanjay J. Mathew et al.
BIOLOGICAL PSYCHIATRY (2008)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
Riluzole in the treatment of mood and anxiety disorders
Christopher Pittenger et al.
CNS DRUGS (2008)
Daily process methodology for measuring earlier antidepressant response
William R. Lenderking et al.
CONTEMPORARY CLINICAL TRIALS (2008)
AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression
S. Chourbaji et al.
FASEB JOURNAL (2008)
Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo
Garry D. Honey et al.
JOURNAL OF NEUROSCIENCE (2008)
The persistence of the placebo response in antidepressant clinical trials
Arif Khan et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
NMDA receptors in clinical neurology: excitatory times ahead
Lorraine V. Kalia et al.
LANCET NEUROLOGY (2008)
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Gerard Sanacora et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Novel drugs and therapeutic targets for severe mood disorders
Sanjay J. Mathew et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus
Leda S. B. Garcia et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: A report from the consortium for research in electroconvulsive therapy
Keith G. Rasmussen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: Relationship to clinical effects in mood disorders
Jing Du et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms
Gerard Sanacora et al.
BIOLOGICAL PSYCHIATRY (2007)
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
R. G. Miller et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression - A multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE)
Charles H. Kellner et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients
Steven P. Cohen et al.
JOURNAL OF PAIN (2006)
Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease
E Fumagalli et al.
EXPERIMENTAL NEUROLOGY (2006)
Report by the ACNP Task Force on response and remission in major depressive disorder
A. John Rush et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine - Implications for glutamatergic and dopaminergic model psychoses and cognitive function
JH Krystal et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data
MD Black
PSYCHOPHARMACOLOGY (2005)
Deep brain stimulation for treatment-resistant depression
HS Mayberg et al.
NEURON (2005)
An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression
CA Zarate et al.
BIOLOGICAL PSYCHIATRY (2005)
The intravenous ketamine test: A predictive response tool for oral dextromethorphan treatment in neuropathic pain
SP Cohen et al.
ANESTHESIA AND ANALGESIA (2004)
An open-label trial of riluzole in patients with treatment-resistant major depression
CA Zarate et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Glutamate as a therapeutic target in psychiatric disorders
DC Javitt
MOLECULAR PSYCHIATRY (2004)
The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression
AJ Rush et al.
BIOLOGICAL PSYCHIATRY (2003)
Melatonin exerts an antidepressant-like effect in the tail suspension test in mice:: evidence for involvement of N-methyl-D-aspartate receptors and the L-arginine-nitric oxide pathway
M Mantovani et al.
NEUROSCIENCE LETTERS (2003)
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
JR Geddes et al.
LANCET (2003)
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function
MF Egan et al.
CELL (2003)
Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model
RJ Knapp et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Prolonged effect of an anesthetic dose of ketamine on behavioral despair
A Yilmaz et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Antidepressant-like effects of aniracetam in aged rats and its mode of action
K Nakamura et al.
PSYCHOPHARMACOLOGY (2001)
Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes
I Mizuta et al.
NEUROSCIENCE LETTERS (2001)
Antidepressant-like actions of an AMPA receptor potentiator (LY392098)
X Li et al.
NEUROPHARMACOLOGY (2001)
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy - A randomized controlled trial
HA Sackeim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine -: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists
A Anand et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
